Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial-Reference-Cited by-同舟云学术

Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial

Published:2022-01-18 Issue:5 Volume:29 Page:390-396
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Elbaz Ramy¹^ORCID,El‐Assmy Ahmed¹,Zahran Mohamed H¹,Hashem Abdelwahab¹²³^ORCID,Shokeir Ahmed A¹

Affiliation:

1. Urology Department, Urology and Nephrology Center Mansoura University Mansoura Egypt

2. Urology Department International Medical Center Cairo Egypt

3. Urology Department National Nephrology and Urology Institute Cairo Egypt

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14792

Reference28 articles.

1. Clinical Efficacy of sildenafil Citrate and Predictors of Long-term Response

2. Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH)

3. Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia

4. Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder

5. The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effects of Vibegron Add-on Therapy on Alpha 1-Blocker Therapy for Sexual Function and Overactive Bladder Symptoms in Benign Prostatic Hyperplasia: A Prospective, Open-Label Study;Journal of Clinical Medicine;2024-07-05

2. Medical Advancements in Benign Prostatic Hyperplasia Treatments;Current Urology Reports;2024-03-07

3. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023;Journal of Urology;2024-01

4. Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron 50 mg in Sexually Active Men With Bothersome Overactive Bladder Symptoms – A Multicenter, Randomized Study;International Neurourology Journal;2023-09-30

5. Conservative Non-surgical Options for Erectile Dysfunction;Current Urology Reports;2022-11-29